Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 539

Cited In for PubMed (Select 8602242)

1.

Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine.

Martino MM, Brkic S, Bovo E, Burger M, Schaefer DJ, Wolff T, Gürke L, Briquez PS, Larsson HM, Gianni-Barrera R, Hubbell JA, Banfi A.

Front Bioeng Biotechnol. 2015 Apr 1;3:45. doi: 10.3389/fbioe.2015.00045. eCollection 2015. Review.

2.

A genome-wide association study in large white and landrace pig populations for number piglets born alive.

Bergfelder-Drüing S, Grosse-Brinkhaus C, Lind B, Erbe M, Schellander K, Simianer H, Tholen E.

PLoS One. 2015 Mar 17;10(3):e0117468. doi: 10.1371/journal.pone.0117468. eCollection 2015.

3.

CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development.

Tu T, Zhang C, Yan H, Luo Y, Kong R, Wen P, Ye Z, Chen J, Feng J, Liu F, Wu JY, Yan X.

Cell Res. 2015 Mar;25(3):275-87. doi: 10.1038/cr.2015.15. Epub 2015 Feb 6.

4.
5.

VEGF189 binds NRP1 and is sufficient for VEGF/NRP1-dependent neuronal patterning in the developing brain.

Tillo M, Erskine L, Cariboni A, Fantin A, Joyce A, Denti L, Ruhrberg C.

Development. 2015 Jan 15;142(2):314-9. doi: 10.1242/dev.115998. Epub 2014 Dec 17.

6.

Hand2 is an essential regulator for two Notch-dependent functions within the embryonic endocardium.

VanDusen NJ, Casanovas J, Vincentz JW, Firulli BA, Osterwalder M, Lopez-Rios J, Zeller R, Zhou B, Grego-Bessa J, De La Pompa JL, Shou W, Firulli AB.

Cell Rep. 2014 Dec 24;9(6):2071-83. doi: 10.1016/j.celrep.2014.11.021. Epub 2014 Dec 11.

7.

Keeping an eye on SOXC proteins.

Pillai-Kastoori L, Wen W, Morris AC.

Dev Dyn. 2015 Mar;244(3):367-76. doi: 10.1002/dvdy.24235. Epub 2014 Dec 21.

PMID:
25476579
8.

Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia.

Ma Q, Zhang L.

Prog Neurobiol. 2015 Jan;124:28-48. doi: 10.1016/j.pneurobio.2014.11.001. Epub 2014 Nov 11.

PMID:
25450949
9.

New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process.

Dehghanian F, Hojati Z, Kay M.

Avicenna J Med Biotechnol. 2014 Oct;6(4):192-9. Review.

10.

The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin/Frizzled4 signaling.

Rattner A, Wang Y, Zhou Y, Williams J, Nathans J.

Invest Ophthalmol Vis Sci. 2014 Nov 20;55(12):8614-25. doi: 10.1167/iovs.14-15693.

PMID:
25414188
11.

Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside.

Al-Halafi AM.

Oman J Ophthalmol. 2014 Sep;7(3):112-5. doi: 10.4103/0974-620X.142591. Review.

12.

Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair.

Johnson KE, Wilgus TA.

Adv Wound Care (New Rochelle). 2014 Oct 1;3(10):647-661. Review.

13.

Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.

Domigan CK, Ziyad S, Iruela-Arispe ML.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):30-9. doi: 10.1161/ATVBAHA.114.303215. Epub 2014 Oct 2. Review.

PMID:
25278287
14.

Modulation of age-related insulin sensitivity by VEGF-dependent vascular plasticity in adipose tissues.

Honek J, Seki T, Iwamoto H, Fischer C, Li J, Lim S, Samani NJ, Zang J, Cao Y.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14906-11. doi: 10.1073/pnas.1415825111. Epub 2014 Sep 30.

15.

Fox(y) regulators of VEGF receptors.

Ricard N, Simons M.

Circ Res. 2014 Sep 26;115(8):683-5. doi: 10.1161/CIRCRESAHA.114.304974. No abstract available.

PMID:
25258399
16.

Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development.

Xiong Y, Yang P, Proia RL, Hla T.

J Clin Invest. 2014 Nov;124(11):4823-8. doi: 10.1172/JCI77685. Epub 2014 Sep 24.

17.

Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding.

Gelfand MV, Hagan N, Tata A, Oh WJ, Lacoste B, Kang KT, Kopycinska J, Bischoff J, Wang JH, Gu C.

Elife. 2014 Sep 22;3:e03720. doi: 10.7554/eLife.03720.

18.

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.

Hoeppner LH, Wang Y, Sharma A, Javeed N, Van Keulen VP, Wang E, Yang P, Roden AC, Peikert T, Molina JR, Mukhopadhyay D.

Mol Oncol. 2015 Jan;9(1):270-81. doi: 10.1016/j.molonc.2014.08.008. Epub 2014 Aug 30.

PMID:
25226814
19.

Control of cellular motility by neuropilin-mediated physical interactions.

Li X, Parker MW, Vander Kooi CW.

Biomol Concepts. 2014 May;5(2):157-66.

PMID:
25018786
20.

Programmed translational readthrough generates antiangiogenic VEGF-Ax.

Eswarappa SM, Potdar AA, Koch WJ, Fan Y, Vasu K, Lindner D, Willard B, Graham LM, DiCorleto PE, Fox PL.

Cell. 2014 Jun 19;157(7):1605-18. doi: 10.1016/j.cell.2014.04.033.

PMID:
24949972
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk